Board of Directors
Guy Diedrich
- As vice chancellor for technology commercialization since 2005, Guy Diedrich directs an effort to bring technologies created by Texas A&M University system researchers to market. He was formerly president of Austin Technology Ventures and CEO of GRA, Inc. Diedrich received his bachelor’s degree from Texas A&M University and is currently pursuing a Ph.D.
- read more
Philip G. Ralston, Jr.
- With more than 35 years in the life science industry as a senior executive, inventor, company founder, venture capitalist and business coach, Phil Ralston has represented companies in public, private and non-profit sectors. He holds 18 patents on various medical products, including drug delivery, monitoring and cardiovascular devices.
- read more
George Chiou, Ph.D.
- Dr. George Chiou led the development of Timolol, one of the highest selling ophthalmic pharmaceuticals, and has more than 30 years of ocular pharmacology and therapeutic experience. He is the owner of 30 patents in the research and development of drugs for ocular diseases. Dr.
- read more
Dennis L. McWilliams
- As founder and CEO of ApolloEndo, Inc., Dennis McWilliams has a broad base of experience in building small companies based on both medical devices and drug therapeutics.
- read more
David Nelson
- Mr. Nelson founded Signature Investor Group, LC in 2004 to develop private equity investment opportunities primarily for institutions and high net worth individuals. Most recently, he formed a company which led the initial $1.2 million capitalization of MacuCLEAR, Inc.
- read more